← Return to ARSI PR wars: Nubeqa (Bayer) vs Erleada (J & J) lawsuit

Discussion
Comment receiving replies
Profile picture for brianjarvis @brianjarvis

@jeffmarc Though I would go by the clinical trial outcomes (rather than the legal arguments in court litigation), I also understand the difficulty in extrapolating those population outcomes to a specific patient’s outcome.

Jump to this post


Replies to "@jeffmarc Though I would go by the clinical trial outcomes (rather than the legal arguments in..."

@brianjarvis But you have to ask yourself: Where is the data coming from? Aren’t these tables based on the data that the drug manufacturers are reporting?